Related Experiment Video
Updated: May 27, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Cognitive dysfunction and antiphospholipid antibodies
Simone Appenzeller1, Aline Tamires Lapa, Jozélio Freire de Carvalho
1Department of Medicine, Faculty of Medical Science, State University of Campinas, Campinas, Brazil.
Abstract:
Antiphospholipid syndrome (APS) is a multisystem prothrombotic condition, however, in recent years, its inflammatory nature has been studied extensively. Cerebral involvement is commonly observed in APS and results in different clinical manifestations. However, most of the studies include secondary APS. In this article, we review the prevalence, clinical characteristics, and physiopathology of cognitive impairment in patients with primary APS.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Dementia l: Introduction
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Hepatic Encephalopathy
Alzheimer Disease l: Introduction
Transient Ischemic Attack l: Introduction

